Financials

News Ideas Discussions Technicals Forecast Seasonals

SONN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Sonnet BioTherapeutics Holdings, Inc. operating, investing, and financing activities

SONN free cash flow for Q3 24 is -3.07 M USD. For 2023, SONN free cash flow was -21.34 M USD and operating cash flow was -21.34 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—